3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Lymphoma, Large B-Cell, Diffuse
7
Prostatic Neoplasms
5
Burkitt Lymphoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Ovarian Neoplasms
2
Lymphoma, Follicular
2
Leukemia, Biphenotypic, Acute
2
Endometrial Neoplasms
2
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Neoplasm Metastasis
1
Neoadjuvant Therapy
1
Myasthenia Gravis
1
Metastatic Castration-resistant Prostate Cancer
1
Lymphoma, Non-Hodgkin
1
Lymphoma, B-Cell
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, B-Cell
1
Heart Failure
1
Dendritic Cell Sarcoma, Interdigitating
1
Colorectal Neoplasms
1
Cardiotoxicity
1
Carcinoma, Non-Small-Cell Lung
1
Bulbo-Spinal Atrophy, X-Linked
1
Brain Neoplasms
1
Biliary Tract Neoplasms
1
Adrenal Insufficiency
1
Interventions
Cyclophosphamide
7
acalabrutinib
4
pirtobrutinib
3
fludarabine
3
Rituximab
3
fludarabine phosphate
2
Vincristine
2
Melphalan
2
Doxorubicin
2
thymoglobulin
1
obinutuzumab
1
idecabtagene vicleucel
1
ibrutinib
1
Stem Cell Transplantation
1
Prednisone
1
Prednisolone
1
Mycophenolic Acid
1
Mesna
1
Immunotherapy, Adoptive
1
Filgrastim
1
Diet
1
Bone Marrow Transplantation
1
ARQ531
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Leukemia, B-Cell
×
Prednisolone
×
Clear all
NCT03899337
2023-01-09
STELLAR
University of Birmingham
Phase 2
Recruiting
105 enrolled